tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market
TRVI
Trevi Therapeutics
RESEARCH TOOLSreports
Want to see TRVI full AI Analyst Report?

Trevi Therapeutics (TRVI) Stock News & Sentiment

589 Followers
Trevi Therapeutics Charts Cash-Rich Path Through Key Trials
Premium
Company Announcements
Trevi Therapeutics Charts Cash-Rich Path Through Key Trials
18d ago
TRVI
Analyst Reiterates Buy on Trevi Therapeutics, Slightly Lowers Price Target to $23 Amid Advancing Haduvio Pipeline
Premium
Ratings
Analyst Reiterates Buy on Trevi Therapeutics, Slightly Lowers Price Target to $23 Amid Advancing Haduvio Pipeline
19d ago
TRVI
Trevi Therapeutics Prices Public Offering to Fund Haduvio
Premium
Company Announcements
Trevi Therapeutics Prices Public Offering to Fund Haduvio
1M ago
8K
TRVI
Trevi Therapeutics: Positive Needham Conference Takeaways Reinforce Buy Rating and Favorable Risk‑Reward Profile
Premium
Ratings
Trevi Therapeutics: Positive Needham Conference Takeaways Reinforce Buy Rating and Favorable Risk‑Reward Profile
1M ago
TRVI
Trevi Therapeutics Maps Phase III Path and Runway
Premium
Company Announcements
Trevi Therapeutics Maps Phase III Path and Runway
2M ago
TRVI
TRVI Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TRVI Earnings this Week: How Will it Perform?
2M ago
TRVI
Trevi Therapeutics Aligns With FDA on Phase 3 Cough Trials
Premium
Company Announcements
Trevi Therapeutics Aligns With FDA on Phase 3 Cough Trials
3M ago
8K
TRVI
More TRVI News >

TRVI News on the Web

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI) and AIM ImmunoTech (AIM)
TipRanks News
Bullish
Why Trevi Therapeutics Stock Is Surging Higher Now
TipRanks News
Bullish
Trevi Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
GuruFocus News
Neutral
Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030
MarketBeat
Bullish
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Joint (JYNT) and ImmunityBio (IBRX)
TipRanks News
Neutral
Trevi Therapeutics price target raised to $30 from $18 at Stifel
TipRanks News
Bullish
Trevi Therapeutics price target raised to $29 from $21 at Clear Street
TipRanks News
Bullish
Why Trevi Therapeutics Stock Is Sliding Despite Hype
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
TRVI
Sector Average
Media Buzz
This Week1 articles
Weekly Average4 articles
News Sentiment
This Week100%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TRVI’s Media Buzz Sentiment?
1 articles about TRVI were published this week. In an average week, 4 articles are published.
    What is TRVI’s weekly average amount of articles?
    In an average week, 4 articles about TRVI are published.
      What is TRVI’s News Sentiment?
      100% of articles about TRVI were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week